NIACINAMIDE 7%: WHAT THE TRIALS SHOW
Three decades of double-blind randomized controlled trials, read straight. The doses, the measurements, and what each one means for the way your face looks. Vector ONE is a 7% niacinamide cream, inside the 5–10% range the studies used.
Niacinamide is the form of vitamin B3 that formulators reach for first, and the reason is unglamorous: it is the most heavily studied ingredient most of us will ever put in a cream. Three decades of double-blind trials have measured it against tone, fine lines, oiliness, roughness and visible redness, and published the numbers either way. Very few cosmetic ingredients carry that much read-through.
What people actually notice with age is not a figure on a chart. It is fine lines that read deeper, tone that goes patchy, texture that roughens, redness that hangs around instead of fading. Those four are exactly what the niacinamide literature has spent thirty years measuring, which is why the ingredient keeps turning up in formulas that have to do more than one job.
It is also small and water-soluble, at 122 Da, which is why it belongs in a leave-on cream rather than something that only sits on the surface. It gets along with almost everything else in the bottle, it does not need an acidic pH to be useful, and it does not oxidise on the shelf. For a night cream carrying seven actives at once, that combination of published evidence and easy formulating is the whole argument for putting it in first and building around it.
Niacinamide is in Vector ONE because it has the widest published appearance record and the fewest formulating objections: water-soluble, stable across a broad pH range, comfortable alongside retinol and acids, and pleasant to use at the dose printed on the label. It is the ingredient the other six actives are built around, not a garnish.
27 women with moderate to severe uneven facial pigmentation (average 6.5 years). One half of the face received 4% niacinamide cream. The other half received 4% hydroquinone cream. Both applied twice daily for 8 weeks with mandatory SPF 50+ during the day. Double-blinded. Randomized left-right assignment.
The niacinamide side produced a 62% reduction in MASI score. Hydroquinone came in slightly higher at 70%. But when objective chromameter readings were taken, the measured lightening was the same on both sides. Both reached an L* luminosity value of 56 by the end of the eight-week trial. The p-value of 0.78 says it plainly: no statistically significant difference in measured lightening between the two. On the instrument, niacinamide read level with its comparator.
Skin samples taken during the same trial counted 26% fewer mast cells on the niacinamide side, 22 cells/mm2 down to 16.3 (p = 0.01). We report it because it is part of what this trial measured, not because a cream can promise it. What it tells us as formulators is that the work was checked under a microscope rather than stopping at photographs.
| MASI score reduction (niacinamide) | p < 0.001 |
| L* luminosity parity vs. HQ | p = 0.78 |
| Melanin measured in the skin samples | p < 0.001 |
| Mast cell count reduction | p = 0.01 |
| Tolerability (niacinamide) | Mild effects only |
| Tolerability (hydroquinone) | Moderate to severe |
Tolerability was not even close. On the niacinamide side the reported effects were mild. On the hydroquinone side they were moderate to severe. The ingredient that kept pace on evenness of tone was also, by a clear margin, the gentler one.
50 Caucasian women aged 40 to 60, each with moderate to marked visible sun-related ageing. 5% niacinamide emulsion on one side of the face, matched vehicle placebo on the other. Twice daily for 12 continuous weeks. Double-blinded and randomized.
21% improvement in fine lines and wrinkles. 14% improvement in skin tone clarity. 15% increase in overall radiance. Statistically significant reductions in hyperpigmented spots, red blotchiness, and sallowness were measured (p < 0.05). Cutometry confirmed significant improvements in gross elasticity. Irritant potential was statistically identical to the placebo vehicle.
The sallowness reduction deserves specific attention. That yellowish cast in older skin is not really pigment. It is what happens when sugars latch onto the proteins that give skin its structure and leave a discoloured residue behind, the same slow browning that darkens food as it cooks. Niacinamide has a long-standing reputation as an antioxidant in cosmetic formulating, and this is one of the few trials that put a measured number on the sallowness end of it rather than simply asserting it.
This is a 12-week, placebo-controlled, split-face read on four separate appearance measures at once: fine lines, tone clarity, radiance and sallowness. That breadth is why niacinamide anchors this formula rather than sitting somewhere down the ingredient list. It is not that any single number is dramatic. It is that four different measurements moved in the same trial, and the irritation score did not.
Two independent trials. Study 1: 18 subjects with brown patches of uneven pigmentation, split-face design, 5% niacinamide vs. vehicle for 8 weeks. Study 2: 120 Japanese women with moderate to deep facial tanning, round-robin design, 2% niacinamide + SPF 15 vs. SPF 15 alone vs. vehicle alone, 8 weeks.
The laboratory arm of this work is worth stating carefully, because it is dish work and not skin. Niacinamide did not change how much pigment was made. What the cell work recorded was a 35 to 68% reduction in how much of that pigment moved across into the neighbouring cells that carry it to the surface. It is a finding about where pigment ends up, measured in a dish, and we cite it as exactly that rather than as something the cream does to your face.
On skin, the group using 2% niacinamide plus SPF 15 recorded significantly higher L* (lightness) readings than the group using SPF 15 alone, which is the part of this work that matters most: the difference was not simply sun protection. Nothing is destroyed to get there, so the effect fades if you stop using it. That is a fair trade for something you can keep using nightly across every skin tone.
The skincare industry rewards bigger numbers on labels. 10% niacinamide. 15%. Even 20%. The assumption is simple: if 5% works, double it and it works twice as well. The published data says the opposite.
Most of the double-blind trials that produced usable results on tone, lines, barrier support and oil control ran niacinamide between 2% and 5%. That is the range the published evidence actually covers. Above it the record thins out quickly, and what there is does not show a matching jump in results.
But a percentage in a study is a snapshot, and a night cream has to hold up for eight hours. Whatever you apply thins out as the night goes on, so a formula that starts a little above the studied range still has a useful amount present at four in the morning. That is the entire argument for sitting in the 6 to 8% band. It is a formulating argument, not a claim that more does more.
The question is not how high the number on the label goes. It is how long a useful amount of it stays on your skin. At 7%, Vector ONE starts above the range the trials used so that there is still something there hours later. Above 10%, the published tolerability data gets noticeably worse while the results data does not get better. 7% is the honest middle.
The Cosmetic Ingredient Review's published safety assessment of niacinamide is the reference point most formulators work from: at up to 5%, cumulative testing across 21 days finds essentially no irritation. Above 10%, reports of stinging, redness and general discomfort turn up often enough to matter. The 6 to 8% band is where you buy staying power without moving into that territory.
The trials cluster between 2% and 5%. The interesting formulating question is not how far above that you can push the number, but how to keep a useful amount of it there all night.
Saturate, reading the aggregated trial data above| 2% to 3%: barrier support, mild oil control | Entry Level |
| 4% to 5%: the range most published trials used | Best Evidenced |
| 6% to 8%: still present hours after you apply it | Where We Sit |
| 10%+: no better results, more reported irritation | Not Worth It |
Use niacinamide at a strength that is still there in the morning, not just at the moment you put it on.
SATURATE
Vector ONE
Vector ONE carries niacinamide at 7%, and the reason is a formulating one. Most of the published work that produced the numbers above ran niacinamide between 2% and 5%, and there is little sign that pushing far past that range buys more. But a night cream has to last the night. Starting at 7% leaves more of it still present in the skin's outer layer hours after you apply it, which is the point of something you sleep in rather than rinse off. It also stays under 10%, where published tolerability data starts to get worse, and it sits deliberately above the doses the studies above actually used. We are telling you our number differs from theirs rather than letting you assume it matches. It is printed on the label so you can check it against every study on this page.
[2] Bissett DL, Oblong JE, Berge CA. Niacinamide: a B vitamin that improves aging facial skin appearance. Dermatol Surg. 2005;31(7 Pt 2):860-5.
[3] Hakozaki T, et al. The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer. Br J Dermatol. 2002;147(1):20-31.
[4] Tanno O, et al. Nicotinamide increases biosynthesis of ceramides as well as other stratum corneum lipids. Br J Dermatol. 2000;143(3):524-31.
[5] Shalita AR, et al. Topical nicotinamide compared with clindamycin gel in the treatment of inflammatory acne vulgaris. Int J Dermatol. 1995;34(6):434-7.
[6] Chen AC, et al. (ONTRAC Trial) A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention. N Engl J Med. 2015;373(17):1618-26.
[7] Cosmetic Ingredient Review Expert Panel. Niacinamide Safety Assessment. Int J Toxicol. 2005.
